Malignancies

15 registered clinical trials studyying Malignancies — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies NCT05602103	University Hospital, Caen	—
Active Not Recruiting	Identifying Tissue-of-origin in Transplant Patients and Patients with Malignancies. NCT06703853	Hadassah Medical Organization	—
Recruiting	Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma NCT05929495	University of Milano Bicocca	Phase 2
Withdrawn	A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies NCT05253105	Shanghai Junshi Bioscience Co., Ltd.	Phase 1
Active Not Recruiting	9-ING-41 in Patients With Advanced Cancers NCT03678883	Actuate Therapeutics Inc.	Phase 2
Completed	A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed o NCT03236857	AbbVie	Phase 1
Completed	Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers NCT03005782	Regeneron Pharmaceuticals	Phase 1
Completed	The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignanci NCT03384511	Shandong Cancer Hospital and Institute	Phase 4
Completed	Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of NCT02521389	MEI Pharma, Inc.	Phase 1
Completed	Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors NCT02257476	Emory University	Phase 1
Completed	Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation Therapy NCT01404728	University of Colorado, Denver	—
Completed	Study of PWT33597 Mesylate in Subjects With Advanced Malignancies NCT01407380	Pathway Therapeutics, Inc.	Phase 1
Terminated	Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies NCT00329329	Agennix	Phase 1
Completed	Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma NCT00316511	Agenus Inc.	Phase 1
Completed	Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) NCT00320827	Daiichi Sankyo	Phase 1